Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers
Introduction: Nanoporous microneedle arrays (npMNA) are being developed as skin patches for vaccine delivery. As alternative for needle-based immunisation, they may potentially result in higher vaccine acceptance, which is important for future mass vaccination campaigns to control outbreaks, such as...
Main Authors: | Manon L.M. Prins, Corine Prins, Jutte J.C. de Vries, Leo G. Visser, Anna H.E. Roukens |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Virus Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0168170223001375 |
Similar Items
-
A case of recurrent fixed drug eruption following the administration of 2 different coronavirus disease 2019 vaccines verified using intradermal and patch tests
by: Jung Eun Seol, MD, PhD, et al.
Published: (2023-03-01) -
Relationship CHANGE: How to Change Your Relationships for GOOD
by: Victor William Harris
Published: (2012-03-01) -
Immunogenicity of a protective intradermal DNA vaccine against lassa virus in cynomolgus macaques
by: Jingjing Jiang, et al.
Published: (2019-09-01) -
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial
by: Abdi Naficy, et al.
Published: (2024-12-01) -
12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial
by: Bingfeng Han, et al.
Published: (2021-11-01)